Kang, H. J., Chang, H. M., Kim, T. W., Ryu, M., Sohn, H. J., Yook, J. H., . . . Kang, Y. (2005). Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy. Nature Publishing Group.
Chicago-стиль цитированияKang, H J., et al. Phase II Study of Capecitabine and Cisplatin As First-line Combination Therapy in Patients With Gastric Cancer Recurrent After Fluoropyrimidine-based Adjuvant Chemotherapy. Nature Publishing Group, 2005.
MLA-цитированиеKang, H J., et al. Phase II Study of Capecitabine and Cisplatin As First-line Combination Therapy in Patients With Gastric Cancer Recurrent After Fluoropyrimidine-based Adjuvant Chemotherapy. Nature Publishing Group, 2005.